Pederipra Spray, 20 mg/ml nahasprei, suspensioon.
Pederipra Spray, 20 mg/ml nahasprei, suspensioon.
Not authorised
- Chlortetracycline
Product identification
Medicine name:
Pederipra Spray, 20 mg/ml nahasprei, suspensioon.
Active substance:
- Chlortetracycline
Target species:
-
Horse
-
Cattle
-
Pig
-
Sheep
-
Goat
-
Dog
-
Cat
-
Poultry
Route of administration:
-
Cutaneous use
Product details
Active substance and strength:
-
Chlortetracycline20.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Cutaneous spray, suspension
Withdrawal period by route of administration:
-
Cutaneous use
-
Horse
-
Milk0day
-
Meat and offal0dayLooma hädatapmisel tuleb välistada manustamiskoha sattumine toidutoorme hulka.
-
-
Cattle
-
Milk0day
-
Meat and offal0dayLooma hädatapmisel tuleb välistada manustamiskoha sattumine toidutoorme hulka.
-
-
Pig
-
Meat and offal0dayLooma hädatapmisel tuleb välistada manustamiskoha sattumine toidutoorme hulka.
-
-
Sheep
-
Milk0day
-
Meat and offal0dayLooma hädatapmisel tuleb välistada manustamiskoha sattumine toidutoorme hulka.
-
-
Goat
-
Milk0day
-
Meat and offal0dayLooma hädatapmisel tuleb välistada manustamiskoha sattumine toidutoorme hulka.
-
-
Poultry
-
Meat and offal0dayLooma hädatapmisel tuleb välistada manustamiskoha sattumine toidutoorme hulka.
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QD06AA02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Estonia
Package description:
- Esmane pakend: hermeetiliselt suletud rõhukonteiner, suletud doseerimissulguri ja plastkapsliga. Teisene pakend: üks rõhukonteiner pakendis (270 ml), mis sisaldab 63 ml nahasprei, suspensiooni ja 137 ml propellenti.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Laboratorios Hipra S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Laboratorios Hipra S.A.
Responsible authority:
- State Agency Of Medicines
Authorisation number:
- 1318
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Estonian (PDF)
Published on: 26/01/2022